col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


5 Ergebisse       Seite 1

 [1] 
Elsevier: Toxicology and Applied Pharmacology
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Aug―06 Development and reproductive safety of AdCLD-CoV19, an adenoviral vector-based COVID-19 vaccine, in female Sprague-Dawley rats and their offspring Sang-Jin Park, Seonghyeon Kim, Sangyun Kim, Kwang-Soo Shin, Chang-Yuil Kang, Eui-Ju Hong, et al. (+5)
2 [GO] 2022―Okt―12 Synergistic action of organophosphates and COVID-19 on inflammation, oxidative stress, and renin-angiotensin system can amplify the risk of cardiovascular maladies Prem Rajak, Sumedha Roy, Sayanti Podder, Moumita Dutta, Saurabh Sarkar, Abhratanu Ganguly, et al. (+4)
3 [GO] 2021―Jan―29 Edible plant-derived exosomal microRNAs: Exploiting a cross-kingdom regulatory mechanism for targeting SARS-CoV-2 Sreeram Peringattu Kalarikkal, Gopinath M. Sundaram
4 [GO] 2020―Sep―11 Safety assessment of drug combinations used in COVID-19 treatment: in silico toxicogenomic data-mining approach Katarina Baralić, Dragica Jorgovanović, Katarina Živančević, Evica Antonijević Miljaković, Biljana Antonijević, Aleksandra Buha Djordjevic, et al. (+2)
5 [GO] 2020―Aug―07 Hydroxyl functionalized multi-walled carbon nanotubes modulate immune responses without increasing 2009 pandemic influenza A/H1N1 virus titers in infected mice Hao Chen, Sara T. Humes, Melanie Rose, Sarah E. Robinson, Julia C. Loeb, Indu V. Sabaraya, et al. (+5)
 [1] 

5 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec